135 related articles for article (PubMed ID: 30970527)
1. Etanercept improved anemia and decreased hepcidin gene expression in a rat model of rheumatoid arthritis.
Elsheemy MS; Hasanin AH; Mansour A; Mehrez SI; Abdel-Bary M
Biomed Pharmacother; 2019 Apr; 112():108740. PubMed ID: 30970527
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan alone or in combination with etanercept improves anemia associated with rheumatoid arthritis in rats: a possible role of anti-inflammatory and reno-protective effects.
Hasanin AH; Mohamed RH
Pharmacol Rep; 2020 Apr; 72(2):379-388. PubMed ID: 32048253
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients.
Song SN; Iwahashi M; Tomosugi N; Uno K; Yamana J; Yamana S; Isobe T; Ito H; Kawabata H; Yoshizaki K
Arthritis Res Ther; 2013 Oct; 15(5):R141. PubMed ID: 24286116
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity.
Swellam M; Gabal KM; Youssef SS
IUBMB Life; 2013 Oct; 65(10):883-8. PubMed ID: 24014495
[TBL] [Abstract][Full Text] [Related]
5. Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus.
Koca SS; Isik A; Ustundag B; Metin K; Aksoy K
Inflammation; 2008 Jun; 31(3):146-53. PubMed ID: 18278547
[TBL] [Abstract][Full Text] [Related]
6. Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis.
Demirag MD; Haznedaroglu S; Sancak B; Konca C; Gulbahar O; Ozturk MA; Goker B
Intern Med; 2009; 48(6):421-6. PubMed ID: 19293540
[TBL] [Abstract][Full Text] [Related]
7. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis.
Kim HR; Kim KW; Yoon SY; Kim SH; Lee SH
J Korean Med Sci; 2010 Mar; 25(3):348-52. PubMed ID: 20191031
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid anemia.
Masson C
Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
[TBL] [Abstract][Full Text] [Related]
9. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis.
Abdel-Khalek MA; El-Barbary AM; Essa SA; Ghobashi AS
J Rheumatol; 2011 Oct; 38(10):2153-9. PubMed ID: 21885483
[TBL] [Abstract][Full Text] [Related]
10. Anti-hyperalgesia effect of nanchelating based nano particle, RAc1, can be mediated via liver hepcidin expression modulation during persistent inflammation.
Nazemian V; Kalanaky S; Manaheji H; Houshmandi E; Mohammadi M; Zaringhalam J; Mirjafai S
Int Immunopharmacol; 2019 Apr; 69():337-346. PubMed ID: 30776642
[TBL] [Abstract][Full Text] [Related]
11. Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study.
Al-Gareeb AIA; Gorial FI; Mahmood AS
Clin Rheumatol; 2018 Oct; 37(10):2633-2641. PubMed ID: 29882203
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis and anemia: the impact of different anti-inflammatory therapies on hemoglobin levels. An observational study.
Calisto Pérez C; León R; León F; Ng SL
Bol Asoc Med P R; 2012; 104(2):34-41. PubMed ID: 23882972
[TBL] [Abstract][Full Text] [Related]
13. Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.
Doyle MK; Rahman MU; Frederick B; Birbara CA; de Vries D; Toedter G; Wu X; Chen D; Ranganath VK; Westerman ME; Furst DE
Rheumatology (Oxford); 2013 Jul; 52(7):1214-9. PubMed ID: 23418046
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.
Theurl M; Nairz M; Schroll A; Sonnweber T; Asshoff M; Haschka D; Seifert M; Willenbacher W; Wilflingseder D; Posch W; Murphy AT; Witcher DR; Theurl I; Weiss G
Haematologica; 2014 Sep; 99(9):1516-24. PubMed ID: 24895335
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis.
Corrado A; Di Bello V; d'Onofrio F; Maruotti N; Cantatore FP
Int J Immunopathol Pharmacol; 2017 Sep; 30(3):302-307. PubMed ID: 28604144
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
17. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis.
Helmy HS; El-Sahar AE; Sayed RH; Shamma RN; Salama AH; Elbaz EM
Int J Nanomedicine; 2017; 12():7015-7023. PubMed ID: 29026298
[TBL] [Abstract][Full Text] [Related]
19. Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis.
Sato H; Takai C; Kazama JJ; Wakamatsu A; Hasegawa E; Kobayashi D; Kondo N; Nakatsue T; Abe A; Ito S; Ishikawa H; Kuroda T; Suzuki Y; Narita I
Sci Rep; 2020 Jun; 10(1):9882. PubMed ID: 32555299
[TBL] [Abstract][Full Text] [Related]
20. Serum Levels of Hepcidin in Rheumatoid Arthritis and Its Correlation with Disease Activity and Anemia: A Meta-analysis.
Chen Y; Xu W; Yang H; Shao M; Xu S; Deng J; Gao X; Liu H; Shuai Z; Xu S; Pan F
Immunol Invest; 2021 Feb; 50(2-3):243-258. PubMed ID: 32216485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
